ALYSSA SHEPHERD: Open Payments
NPI 1881357853 · GAHANNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 21 payments from 12 companies in 2025. Trend: 2023 $1,038 · 2024 $1,111 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $373 |
| BLUEWIND MEDICAL | 1 | $165 |
| Antares Pharma, Inc. | 3 | $65 |
| Ferring Pharmaceuticals Inc. | 3 | $51 |
| Teleflex LLC | 3 | $46 |
| UROGEN PHARMA, INC. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $24 |
| COLOPLAST CORP | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| IMMUNITYBIO, INC. | 1 | $19 |
Products named: GEMTESA, REVI, XYOSTED, ADSTILADRIN, ZUSDURI, ERLEADA, Titan, XTANDI.
Industry payments across OH — which companies pay providers there.
